Disequilibrating azobenzenes by visible-light sensitization under confinement

Photoisomerization of azobenzenes from their stable E isomer to the metastable Z state is the basis of numerous applications of these molecules. However, this reaction typically requires ultraviolet light, which limits applicability. In this study, we introduce disequilibration by sensitization under confinement (DESC), a supramolecular approach to induce the E-to-Z isomerization by using light of a desired color, including red. DESC relies on a combination of a macrocyclic host and a photosensitizer, which act together to selectively bind and sensitize E-azobenzenes for isomerization. The Z isomer lacks strong affinity for and is expelled from the host, which can then convert additional E-azobenzenes to the Z state. In this way, the host–photosensitizer complex converts photon energy into chemical energy in the form of out-of-equilibrium photostationary states, including ones that cannot be accessed through direct photoexcitation

Disequilibrating azoarenes by visible-light sensitization under confinement

The process of vision begins with the absorption of light by retinal, which triggers isomerization around a double bond and, consequently, a large conformational change in the surrounding protein opsin. However, certain organisms evolved different visual systems; for example, deep-sea fishes employ chlorophyll-like antennas capable of capturing red light and sensitizing the nearby retinal molecule via an energy-transfer process. Similar to retinal, most synthetic photochromic molecules, such as azobenzenes and spiropyrans, switch by double-bond isomerization. However, this reaction typically requires shortwavelength (ultraviolet) light, which severely limits the applicability of these molecules. Here, we introduce DisEquilibration by Sensitization under Confinement (DESC) – a supramolecular approach to switch various azoarenes from the E isomer to the metastable Z isomer using visible light of desired color, including red. DESC relies on a combination of a coordination cage and a photosensitizer (PS), which act together to bind and selectively sensitize E-azoarenes. After switching to the Z isomer, the azoarene loses its affinity to—and is expelled from—the cage, which can convert additional copies of E into Z. In this way, the cage⋅PS complex acts as a light-driven supramolecular machine, converting photon energy into chemical energy in the form of out-of-equilibrium photostationary states, including ones that cannot be accessed via direct photoexcitation

Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS

Stabilization of amorphous formulations via mesoporous silica has gained considerable attention for oral delivery of poorly soluble drugs. The release of the drug from the silica is expected to generate supersaturation which is often associated with subsequent precipitation. The aim of the study was hence to develop a novel supersaturable amorphous formulation through the co-loading of a BCS class II drug Celecoxib (CXB) with a precipitation inhibitor hydroxypropyl methylcellulose acetate succinate (HPMCAS) onto the silica. The addition of HPMCAS did not hamper the adsorption but on the contrary promoted the complete solid state conversion of the drug as proved by DSC analysis. In an in vitro pH shift assay, the CXB-HPMCAS co-loaded silica achieved a 5-fold solubility increase over the crystalline CXB and over the CXB-loaded silica blended with HPMCAS which did not show any enhancement. The drug co-loaded silica was then suspended in an aqueous vehicle facilitating the dosing to animals. The CXB-HPMCAS co-loaded silica suspension achieved 15-fold solubility increase in vitro over the crystalline counterpart which translated in 1.35-fold Cmax increase in vivo after oral dosing in rats. This approach represents a novel formulation strategy to maximize in vivo exposure of poorly soluble drugs critical for discovery studies